论文部分内容阅读
目的 评估氟铁龙在治疗与预防膀胱肿瘤中的临床价值。方法 将 10 3例膀胱肿瘤患者随机分成口服氟铁龙预防肿瘤复发组、治疗性口服氟铁龙组、膀胱内灌注丝裂霉素组和对照组 ,进行随访观察。结果 氟铁龙组复发率为 8.8% ,丝裂霉素组复发率为 12 .5 % ,两组比较差异无显著性意义 (P>0 .0 5 ) ;而与对照组复发率(40 % )比较差异有显著性意义 (P<0 .0 1)。氟铁龙治疗膀胱癌的有效率为 33.3%。结论 氟铁龙能有效地治疗和预防膀胱肿瘤的复发 ,毒副反应低 ,使用方便 ,易于临床推广。
Objective To evaluate the clinical value of freon in the treatment and prevention of bladder cancer. Methods A total of 103 patients with bladder cancer were randomly divided into two groups: prevention of tumor recurrence by oral administration of ferrofloxacin, treatment of oral administration of flutamide, and intravesical instillation of mitomycin and control group. The patients were followed up. Results The recurrence rate of FITRON group was 8.8% and that of mitomycin group was 12.5%. There was no significant difference between the two groups (P> 0.05) ) Was significantly different (P <0. 01). The effective rate of the treatment of bladder cancer was 33.3%. Conclusion: It can effectively treat and prevent the recurrence of bladder cancer with low toxic and side effect, easy to use and easy to popularize.